Author:
VanderMolen Karen M,McCulloch William,Pearce Cedric J,Oberlies Nicholas H
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference75 articles.
1. Kurdistani, S. K. Histone modifications as markers of cancer prognosis: a cellular view. Br. J. Cancer 97, 1–5 (2007).
2. Emanuele, S., Lauricella, M. & Tesoriere, G. Histone deacetylase inhibitors: apoptotic effects and clinical implications (review). Int. J. Oncol. 33, 637–646 (2008).
3. Glaser, K. B. HDAC inhibitors: clinical update and mechanism-based potential. Biochem. Pharmacol. 74, 659–671 (2007).
4. Zheng, Y. G., Wu, J., Chen, Z. & Goodman, M. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy. Med. Res. Rev. 28, 645–687 (2008).
5. Kuo, M. H. & Allis, C. D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20, 615–626 (1998).
Cited by
265 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献